Respiratory Medicine
Volume 104, Issue 1 , Pages 52-60 , January 2010

Impact of chronic obstructive pulmonary disease (COPD) on attention functions

  • M. Klein

      Affiliations

    • Department of Pulmology, Krankenhaus Hietzing, 1130 Wien, Austria
    • Karl Landsteiner Institute of Clinical and Experimental Pneumology, Wien, Austria
    • Corresponding Author InformationCorresponding author at: Pädagogischer Fachdienst, Assista Soziale Dienste GmbH, Hueb 10, 4674 Altenhof, Austria. Tel.: +43 664 80631638; fax: +43 7735 6631 120.
    • ,
  • S. Gauggel

      Affiliations

    • Institute of Medical Psychology, University Hospital of the RWTH, D-52074 Aachen, Germany
    • ,
  • G. Sachs

      Affiliations

    • Department of Psychiatry, Allgemeines Krankenhaus Universität, 1090 Wien, Austria
    • ,
  • W. Pohl

      Affiliations

    • Department of Pulmology, Krankenhaus Hietzing, 1130 Wien, Austria
    • Karl Landsteiner Institute of Clinical and Experimental Pneumology, Wien, Austria

Received 2 April 2009 ,Accepted 14 August 2009.

References 

  1. Incalzi RA, Gemma A, Marra C, Capparella O, Fuso L, Carbonin P. Verbal memory impairment in COPD: its mechanisms and clinical relevance. Chest. 1997;112:1506–1513
  2. Hjalmarsen A, Waterloo K, Dahl A, Jorde R, Viitanen M. Effect of long-term oxygen therapy on cognitive and neurological dysfunction in chronic obstructive pulmonary disease. Eur Neurol. 1999;42:27–35
  3. Etnier JL, Berry M. Fluid intelligence in an older COPD sample after short- or long-term exercise. Med Sci Sports Exerc. 2001;33:1620–1628
  4. Kozora E, Make BJ. Cognitive improvement following rehabilitation in patients with COPD. Chest. 2000;117(5 Suppl. 1):249
  5. Orth M, Kotterba S, Duchna K, Widdig W, Rasche K, Schultze-Werninghaus G, et al. Cognitive deficits in patients with chronic obstructive pulmonary disease (COPD). Pneumologie. 2006;60:593–599
  6. Antonelli Incalzi R, Marra C, Giordano A, Calcagni ML, Cappa A, Basso S, et al. Cognitive impairment in chronic obstructive pulmonary disease – a neuropsychological and spect study. J Neurol. 2003;250:325–332
  7. Antonelli-Incalzi R, Corsonello A, Trojano L, Acanfora D, Spada A, Izzo O, et al. Correlation between cognitive impairment and dependence in hypoxemic COPD. J Clin Exp Neuropsychol. 2007;21:1–10
  8. Meek PM, Lareau SC, Anderson D. Memory for symptoms in COPD patients: how accurate are their reports?. Eur Respir J. 2001;18:474–481
  9. Fan J, Wu Y, Fossella JA, Posner MI. Assessing the heritability of attentional networks. BMC Neurosci. 2001;2:14
  10. Fan J, McCandliss BD, Sommer T, Raz A, Posner MI. Testing the efficiency and independence of attentional networks. J Cogn Neurosci. 2002;14:340–347
  11. Wiener Testsystem [Vienna Test System]. Mödling: Dr. G. Schuhfried GmbH.
  12. Raven J, Raven JC, Court JH. Raven manual: section 1, general overview. Oxford, UK: Oxford Psychol. Press Ltd; 1998;
  13. Rosenthal R. Parametric measures of effect size. In:  Cooper H,  Hedges LV editor. The handbook of research synthesis. New York: Sage; 1994;p. 231–244
  14. Celli BR, MacNee W, ATS/ERS Task Force . Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932–946
  15. Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S, Carrozzi L. Definition, epidemiology and natural history of COPD. Eur Respir J. 2007;30:993–1013
  16. Brugger P. SNARC, SCARC, SMARC and SPARC. Are there non-spatial magnitudes?. J Neuropsych. 2008;4:271–274
  17. Kirkil G, Tug T, Ozel E, Bulut S, Tekatas A, Muz MH. The evaluation of cognitive functions with P300 test for chronic obstructive pulmonary disease patients in attack and stable period. Clin Neurol Neurosurg. 2007;109:553–560
  18. Takabatake N, Nakamura H, Abe S, Inoue S, Hino T, Saito H, et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161:1179–1184
  19. Pletz MW, Ioanas M, de Roux A, Burkhardt O, Lode H. Reduced spontaneous apoptosis in peripheral blood neutrophils during exacerbation of COPD. Eur Respir J. 2004;23:532–537
  20. Sin DD, Lacy P, York E, Man SF. Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170:760–765
  21. Vernooy JH, Kücükaycan M, Jacobs JA, Chavannes NH, Buurman WA, Dentener MA, et al. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am J Respir Crit Care Med. 2002;166:1218–1224
  22. Dahl M, Vestbo J, Lange P, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175:250–255
  23. Vassilakopoulos T, Roussos C, Zakynthinos S. The immune response to resistive breathing. Eur Respir J. 2004;24:1033–1043
  24. Wouters EF. Chronic obstructive pulmonary disease. 5: systemic effects of COPD. Thorax. 2002;57:1067–1070
  25. Walter RE, Beiser A, Givelber RJ, O'Connor GT, Gottlieb DJ. Association between glycemic state and lung function: the Framingham heart study. Am J Respir Crit Care Med. 2003;167:911–916
  26. Eid AA, Ionescu AA, Nixon LS, Lewis-Jenkins V, Matthews SB, Griffiths TL, et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164:1414–1418
  27. Wouters EF, Creutzberg EC, Schols AM. Systemic effects in COPD. Chest. 2002;121:127S–130S

PII: S0954-6111(09)00275-3

doi: 10.1016/j.rmed.2009.08.008

Respiratory Medicine
Volume 104, Issue 1 , Pages 52-60 , January 2010

Article Tools

* Image Usage & Resolution